Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2019-04-18 Director's Dealing
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
VOLPI CARLO Comunicato internal dealing
Director's Dealing Classification · 1% confidence The document is a formal notification, indicated by the header 'Informazione Regolamentata' (Regulated Information) and the date/time stamps typical of regulatory dissemination systems (AIM -Italia/Mercato Alternativo del Capitale). The subject line explicitly states 'VOLPI CARLO Comunicato internal dealing' (VOLPI CARLO Internal Dealing Communication). The body contains a template titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This structure and content directly correspond to reporting insider transactions by directors or management, which maps precisely to the 'Director's Dealing' category.
2019-04-18 Italian
LACORTE ROBERTO Comunicato internal dealing
Director's Dealing Classification · 1% confidence The document is a formal notification, identified by the header 'Informazione Regolamentata' (Regulated Information) and the date/time stamps typical of regulatory filings. The 'Oggetto' (Subject) is 'dealing'. Crucially, the template title is 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This explicitly describes insider trading or director's dealing activity. This matches the definition for Director's Dealing (DIRS). The document is short and contains the full disclosure, not just an announcement of a forthcoming report.
2019-04-18 Italian
LACORTE ANDREA Comunicato internal dealing
Director's Dealing Classification · 1% confidence The document is a formal notification, indicated by the header 'Informazione Regolamentata' (Regulated Information) and the date/time stamps typical of regulatory dissemination systems (AIM -Italia/Mercato Alternativo del Capitale). The 'Oggetto' (Subject) is explicitly 'dealing'. The template used is titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This structure precisely matches the requirements for reporting insider transactions by directors or management, which corresponds to the 'Director's Dealing' category.
2019-04-18 Italian
CS - Pharmanutra comunicato ex. art 17 Regolamento AIM
Major Shareholding Notification Classification · 1% confidence The document is titled 'COMUNICAZIONE AI SENSI DELL'ART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA' (Communication pursuant to Article 17 of the AIM Italia Issuers Regulation) and explicitly details changes in the shareholdings of key individuals (Andrea Lacorte, Roberto Lacorte, Beda S.r.l., Gianni Lazzarini). This type of mandatory disclosure regarding changes in significant ownership thresholds (crossing above or below 5%) is specifically covered by the definition for Major Shareholding Notification. The document reports the new ownership percentages (e.g., 32.21%, 23.95%, 11.31%) and confirms that one party dropped below the 5% threshold. This directly corresponds to the 'Major Shareholding Notification' category (MRQ).
2019-04-16 Italian
CS Pharmanutra dimissioni amministratore
Board/Management Information Classification · 1% confidence The document is a formal communication (Informazione Regolamentata) from Pharmanutra S.p.A. dated April 16, 2019. The subject line ('Oggetto') explicitly states 'CS Pharmanutra dimissioni amministratore' (Press Release Pharmanutra resignation of director). The body confirms the irrevocable resignation of a Board Member (Consigliere di Amministrazione), Gianni Lazzarini. This content directly relates to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is moderate (4957 chars), and it is the primary announcement, not just a notice of publication.
2019-04-16 Italian
CS PHARMANUTRA cessione azioni tra soci di riferimento
Director's Dealing Classification · 1% confidence The document is an official communication ('Informazione Regolamentata') from Pharmanutra S.p.A. dated April 16, 2019. The subject ('Oggetto') is 'CS PHARMANUTRA cessione azioni tra soci di riferimento' (Share transfer between reference shareholders). The content details transactions where reference shareholders increased their stake through acquisitions and sales of shares, including reverse book building and lock-up continuity. This type of announcement, concerning changes in significant share ownership or insider transactions by directors/major shareholders, strongly aligns with either Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the core of the announcement is about the reference shareholders (insiders/directors) restructuring their holdings, and it involves specific percentage changes (4.54%, 3.51%), it fits best under the category describing changes in significant ownership or insider activity. Given the focus on the transfer of shares among controlling parties, DIRS (Director's Dealing) or MRQ (Major Shareholding Notification) are the closest fits. Since it details the resulting ownership percentages of the main shareholders (32.21%, 23.95%, 11.31%), MRQ is highly appropriate. However, DIRS specifically covers personal share transactions by directors/executives. Because the transaction involves the President and Vice-President directly restructuring their holdings, DIRS is a strong candidate. Let's re-evaluate the definitions: DIRS is for personal share transactions by directors/executives. MRQ is for notification of changes in significant share ownership levels (crossing thresholds). Since the document explicitly details the resulting ownership percentages of the key individuals (Andrea Lacorte, Roberto Lacorte, Beda S.r.l.), MRQ is the most precise fit for reporting the resulting major shareholding structure change, even though it involves directors. If the document were purely about a single director buying/selling, DIRS would be better. As it details the aggregate change in control block ownership, MRQ is selected.
2019-04-16 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.